BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30955239)

  • 1. Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.
    Zhang C; Guo W; Cheng Y; Li Q; Yang X; Dai R; Zhu L; Chen W
    Mol Genet Genomic Med; 2019 May; 7(5):e574. PubMed ID: 30955239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.
    He Y; Yang H; Geng T; Feng T; Yuan D; Kang L; Luo M; Jin T
    Int J Clin Exp Pathol; 2015; 8(10):13293-303. PubMed ID: 26722533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China.
    Wang Y; Peng L; Lu H; Zhang Z; Xing S; Li D; He C; Jin T; Wang L
    Pharmgenomics Pers Med; 2021; 14():1647-1660. PubMed ID: 34949935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China.
    Yan M; Li D; Zhao G; Li J; Niu F; Li B; Chen P; Jin T
    Gene; 2018 Mar; 648():54-62. PubMed ID: 29337087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of pharmacogenomic VIP variants in the Kyrgyz population from northwest China.
    Yunus Z; Liu L; Wang H; Zhang L; Li X; Geng T; Kang L; Jin T; Chen C
    Gene; 2013 Oct; 529(1):88-93. PubMed ID: 23954225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province.
    Cheng Y; Dai R; Chen W; Li Q; Zhang C; Yang T
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1231. PubMed ID: 32347657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of pharmacogenomic VIP variants in Li nationality of southern China.
    Ding Y; He P; He N; Li Q; Sun J; Yao J; Yi S; Xu H; Wu D; Wang X; Jin T
    Environ Toxicol Pharmacol; 2016 Mar; 42():237-42. PubMed ID: 26901752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomic landscape of VIP genetic variants in Jordanian Arabs and comparison with worldwide populations.
    Al-Eitan LN
    Gene; 2020 May; 737():144408. PubMed ID: 32007583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.
    Li D; Peng L; Xing S; He C; Jin T
    BMC Genom Data; 2021 Nov; 22(1):51. PubMed ID: 34798807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China.
    Chen W; Ding H; Cheng Y; Li Q; Dai R; Yang X; Zhang C
    Mol Genet Genomic Med; 2019 Sep; 7(9):e884. PubMed ID: 31361092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Polymorphisms Analysis of Pharmacogenomic VIP Variants in Miao Ethnic Group of Southwest China.
    Jin T; Aikemu A; Zhang M; Geng T; Feng T; Kang L; Luo ML
    Med Sci Monit; 2015 Dec; 21():3769-76. PubMed ID: 26632549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in very important pharmacogenomic (VIP) variants in the Tibetan population.
    Jin TB; Xun XJ; Shi XG; Yuan DY; Feng T; Geng TT; Kang LL
    Genet Mol Res; 2015 Oct; 14(4):12497-504. PubMed ID: 26505400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms study of pharmacogenomic VIP variants in Han ethnic of China's Shaanxi province.
    Jin T; Zhao R; Shi X; He N; He X; Ouyang Y; Wang H; Wang B; Kang L; Yuan D
    Environ Toxicol Pharmacol; 2016 Sep; 46():27-35. PubMed ID: 27414743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province.
    Dou X; Yang S; Zhang W; Meng W; Zhao W; Hao J; Hu X; Guo L; Jin T
    Gene; 2022 Nov; 844():146825. PubMed ID: 35995116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China.
    Jin T; Shi X; Wang L; Wang H; Feng T; Kang L
    BMC Genet; 2016 May; 17(1):70. PubMed ID: 27233804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in very important pharmacogenomic variants in the Zhuang ethnic group of Southwestern China: A cohort study in the Zhuang population.
    Li J; Guo C; Yan M; Niu F; Chen P; Li B; Jin T
    Medicine (Baltimore); 2018 Apr; 97(17):e0559. PubMed ID: 29703042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation of pharmacogenomic VIP variants in the Chinese Li population: an updated research.
    Yang S; Dou X; Wang Z; Zhang W; Ding K; Meng W; Li H; Liu J; Liu Y; Jin T
    Mol Genet Genomics; 2022 Mar; 297(2):407-417. PubMed ID: 35146537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China.
    Wang L; Aikemu A; Yibulayin A; Du S; Geng T; Wang B; Zhang Y; Jin T; Yang J
    BMC Genet; 2015 Jun; 16():66. PubMed ID: 26091847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of VIP variants in the Tajik ethnic group of northwest China.
    Zhang J; Jin T; Yunus Z; Li X; Geng T; Wang H; Cui Y; Chen C
    BMC Genet; 2014 Sep; 15():102. PubMed ID: 25266489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of very important pharmacogene variants in the Tibetan population from China.
    Rong H; Dong H; He X; Yuan D; Bai M; Wang L; Liu T; He Y; Zheng J; Wang Y; Jin T
    Clin Exp Pharmacol Physiol; 2021 May; 48(5):668-678. PubMed ID: 32311112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.